In this study, we evaluated a novel EC2319 construct that uses the high-affinity FA ligand to facilitate the specific delivery of AMT to FRβ expressing cells in accelerated anti-GBM GN in WKY rats. This evidence concerns the gene FOLR2 and ganglioneuroma.